Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospit. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Yatharth Hospital & Trauma Care Services Ltd

₹ 637 -1.15%
01 Aug - close price
yatharthhospitals.com BSE: 543950 NSE: YATHARTH
About

Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]

Key Points

Hospital Portfolio: [1]
- Total Hospitals: 7 hospitals across North India with 87% of the beds in Metro.

Locations and Beds:[2]
- Greater Noida: 400 beds (112 ICU beds, 66% occupancy).
- Noida: 250 beds (81 ICU beds, 83% occupancy).
- Noida Extension: 450 beds (125 ICU beds, 60% occupancy).
- Jhansi-Orchha: 305 beds (76 ICU beds, 47% occupancy).
- Greater Faridabad: 200 beds (61 ICU beds, ramping up at 28% occupancy).

  • Upcoming Hospitals[3]
    • Model Town, Delhi: ~300 beds.
    • Faridabad (new hospital): ~400 beds.
Website BSE NSE
  • Market Cap ₹ 6,133 Cr.
  • Current Price ₹ 637
  • High / Low ₹ 693 / 345
  • Stock P/E 47.0
  • Book Value ₹ 167
  • Dividend Yield 0.00 %
  • ROCE 13.8 %
  • ROE 10.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 152% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Working capital days have increased from 94.6 days to 137 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
111 128 138 144 155 171 167 178 212 218 219 232
85 94 101 105 113 126 120 131 158 163 164 175
Operating Profit 26 34 36 38 41 46 46 47 54 55 55 57
OPM % 23% 26% 26% 27% 27% 27% 28% 26% 25% 25% 25% 25%
1 1 1 1 1 4 5 6 4 3 4 5
Interest 4 5 6 6 6 3 0 0 3 2 2 1
Depreciation 6 6 7 8 7 7 8 8 11 16 17 13
Profit before tax 16 23 24 25 29 40 44 44 43 40 40 49
Tax % 30% 30% 12% 31% 35% 30% 33% 13% 29% 23% 24% 20%
11 16 21 17 19 28 29 38 30 31 30 39
EPS in Rs 1.68 2.47 3.24 2.64 2.91 3.21 3.44 4.47 3.54 3.61 3.16 4.02
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
71 78 91 136 215 375 478 635 880
53 60 71 98 147 263 343 453 660
Operating Profit 18 18 20 38 68 112 135 182 220
OPM % 25% 24% 22% 28% 32% 30% 28% 29% 25%
0 0 0 0 1 2 3 16 16
Interest 6 5 7 20 20 23 23 11 8
Depreciation 7 6 8 21 21 28 28 29 57
Profit before tax 5 8 5 -2 28 63 88 157 172
Tax % 41% 23% 21% -18% 30% 30% 25% 27% 24%
3 6 4 -2 20 44 66 114 131
EPS in Rs 2.21 3.75 2.43 -0.79 11.09 6.74 10.04 13.33 13.55
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 45%
3 Years: 33%
TTM: 39%
Compounded Profit Growth
10 Years: %
5 Years: 152%
3 Years: 44%
TTM: 14%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 42%
Return on Equity
10 Years: %
5 Years: 18%
3 Years: 16%
Last Year: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 14 16 16 16 16 66 66 86 96
Reserves 29 41 39 38 56 51 117 788 1,509
85 125 175 194 193 264 267 85 12
10 11 26 39 43 45 36 60 114
Total Liabilities 138 193 257 287 309 426 486 1,019 1,731
54 53 164 189 251 303 299 442 605
CWIP 64 110 65 62 0 0 0 0 222
Investments 0 0 0 0 0 0 0 0 74
20 30 27 36 58 123 187 577 830
Total Assets 138 193 257 287 309 426 486 1,019 1,731

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
25 17 17 39 44 60 64 -3 150
-50 -51 -78 -43 -21 -52 -20 -226 -420
26 43 47 5 -19 -1 -18 304 520
Net Cash Flow 1 9 -13 1 3 7 26 75 249

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 58 44 48 45 62 83 82 131 125
Inventory Days 47 42 88 72 43
Days Payable 127 106 490 347 60
Cash Conversion Cycle -22 -20 -354 -229 62 83 82 131 108
Working Capital Days 44 29 -75 -89 -18 0 29 118 137
ROCE % 8% 6% 7% 18% 26% 27% 24% 14%

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
66.33% 66.44% 66.54% 66.54% 66.54% 61.44% 61.64% 61.64%
5.42% 2.59% 3.99% 4.90% 6.28% 9.78% 4.45% 4.34%
8.88% 8.81% 9.30% 9.40% 6.97% 11.50% 13.56% 13.52%
19.37% 22.15% 20.15% 19.16% 20.20% 17.27% 20.35% 20.50%
No. of Shareholders 50,11351,74346,56751,91662,61673,25185,66881,440

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls